Brittle cornea syndrome: current perspectives [Response to Letter]

Andrew Walkden,1,2 Emma Burkitt-Wright,3,4 Leon Au1,2 1Manchester Royal Eye Hospital, Manchester University Foundation Trust, Manchester, UK; 2Medical Academic Health Sciences Centre, University of Manchester, UK; 3Genetic Medicine, Institute of Human Development, Faculty of Medical and Human Scienc...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Walkden A, Burkitt-Wright E, Au L
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2019
Materias:	Ophthalmology RE1-994
Acceso en línea:	https://doaj.org/article/ed630e5cbf754788a4bdd16b1c4d293b
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:ed630e5cbf754788a4bdd16b1c4d293b
record_format	dspace
spelling	oai:doaj.org-article:ed630e5cbf754788a4bdd16b1c4d293b2021-12-02T02:50:26ZBrittle cornea syndrome: current perspectives [Response to Letter]1177-5483https://doaj.org/article/ed630e5cbf754788a4bdd16b1c4d293b2019-09-01T00:00:00Zhttps://www.dovepress.com/brittle-cornea-syndrome-current-perspectives-response-to-letter-peer-reviewed-article-OPTHhttps://doaj.org/toc/1177-5483Andrew Walkden,1,2 Emma Burkitt-Wright,3,4 Leon Au1,2 1Manchester Royal Eye Hospital, Manchester University Foundation Trust, Manchester, UK; 2Medical Academic Health Sciences Centre, University of Manchester, UK; 3Genetic Medicine, Institute of Human Development, Faculty of Medical and Human Sciences, University of Manchester, Manchester, UK; 4Genetic Medicine, St Mary’s Hospital, Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UKCorrespondence: Andrew WalkdenManchester Royal Eye Hospital, Manchester University Foundation Trust, Oxford Road, Manchester M13 9WL, UK, Tel +44 779 215 3269Email walkdenandrew@gmail.com We would like to thank Srirampur and colleagues for their comments with regards to our review article on Brittle Cornea Syndrome, and we are delighted to learn that they agree with our approach to managing a rare, complex and devastating condition.We thank them for highlighting the difficulties associated with suturing such thin and friable corneal tissue, and this issue has been touched upon by other colleagues within the literature.1–3 Your comments on post operative management in terms of suture rotation and steroid titration are interesting and well thought out, and the aim of increasing stromal collagen deposition and more effective healing should be encouraged. We will certainly apply these principles in future cases.We commend our colleagues from Hyderabad, India for their valuable comments and we would welcome any further thoughts from other colleagues around the world that have had the opportunity to manage such a rare and challenging condition.This is in response to the Letter to the EditorView the original paper by Walkden and colleaguesWalkden ABurkitt-Wright EAu LDove Medical PressarticleOphthalmologyRE1-994ENClinical Ophthalmology, Vol Volume 13, Pp 1895-1896 (2019)
institution	DOAJ
collection	DOAJ
language	EN
topic	Ophthalmology RE1-994
spellingShingle	Ophthalmology RE1-994 Walkden A Burkitt-Wright E Au L Brittle cornea syndrome: current perspectives [Response to Letter]
description	Andrew Walkden,1,2 Emma Burkitt-Wright,3,4 Leon Au1,2 1Manchester Royal Eye Hospital, Manchester University Foundation Trust, Manchester, UK; 2Medical Academic Health Sciences Centre, University of Manchester, UK; 3Genetic Medicine, Institute of Human Development, Faculty of Medical and Human Sciences, University of Manchester, Manchester, UK; 4Genetic Medicine, St Mary’s Hospital, Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UKCorrespondence: Andrew WalkdenManchester Royal Eye Hospital, Manchester University Foundation Trust, Oxford Road, Manchester M13 9WL, UK, Tel +44 779 215 3269Email walkdenandrew@gmail.com We would like to thank Srirampur and colleagues for their comments with regards to our review article on Brittle Cornea Syndrome, and we are delighted to learn that they agree with our approach to managing a rare, complex and devastating condition.We thank them for highlighting the difficulties associated with suturing such thin and friable corneal tissue, and this issue has been touched upon by other colleagues within the literature.1–3 Your comments on post operative management in terms of suture rotation and steroid titration are interesting and well thought out, and the aim of increasing stromal collagen deposition and more effective healing should be encouraged. We will certainly apply these principles in future cases.We commend our colleagues from Hyderabad, India for their valuable comments and we would welcome any further thoughts from other colleagues around the world that have had the opportunity to manage such a rare and challenging condition.This is in response to the Letter to the EditorView the original paper by Walkden and colleagues
format	article
author	Walkden A Burkitt-Wright E Au L
author_facet	Walkden A Burkitt-Wright E Au L
author_sort	Walkden A
title	Brittle cornea syndrome: current perspectives [Response to Letter]
title_short	Brittle cornea syndrome: current perspectives [Response to Letter]
title_full	Brittle cornea syndrome: current perspectives [Response to Letter]
title_fullStr	Brittle cornea syndrome: current perspectives [Response to Letter]
title_full_unstemmed	Brittle cornea syndrome: current perspectives [Response to Letter]
title_sort	brittle cornea syndrome: current perspectives [response to letter]
publisher	Dove Medical Press
publishDate	2019
url	https://doaj.org/article/ed630e5cbf754788a4bdd16b1c4d293b
work_keys_str_mv	AT walkdena brittlecorneasyndromecurrentperspectivesresponsetoletter AT burkittwrighte brittlecorneasyndromecurrentperspectivesresponsetoletter AT aul brittlecorneasyndromecurrentperspectivesresponsetoletter
_version_	1718402135922573312

Brittle cornea syndrome: current perspectives [Response to Letter]

Ejemplares similares